NFKB1 and neoplasm: This pro-oncogenic effect may be attributable to EV-carried miRNAs, arsenic-induced EVs from hepatic epithelial cells, for example, deliver miR-155-5p, activating NF-κB and creating a tumor-favorable inflammatory microenvironment (124).